Related references
Note: Only part of the references are listed.Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor
Hideaki Ogiwara et al.
CARCINOGENESIS (2013)
Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line
Shatha AbuHammad et al.
GENOMICS (2013)
ERK1/2 activity contributes to gemcitabine resistance in pancreatic cancer cells
Chunning Zheng et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2013)
Curcumin enhances TRAIL-induced apoptosis of breast cancer cells by regulating apoptosis-related proteins
Sojung Park et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family
N. Skrypek et al.
ONCOGENE (2013)
Sensitivity of Malignant Peripheral Nerve Sheath Tumor Cells to TRAIL Is Augmented by Loss of NF1 through Modulation of MYC/MAD and Is Potentiated by Curcumin through Induction of ROS
David E. Reuss et al.
PLOS ONE (2013)
Curcumin Enhances the Effect of Chemotherapy against Colorectal Cancer Cells by Inhibition of NF-κB and Src Protein Kinase Signaling Pathways
Mehdi Shakibaei et al.
PLOS ONE (2013)
Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil
B. S. Vinod et al.
CELL DEATH & DISEASE (2013)
Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
Baoxu Pang et al.
NATURE COMMUNICATIONS (2013)
Drug Resistance and the Role of Combination Chemotherapy in Improving Patient Outcomes
Denise A. Yardley
INTERNATIONAL JOURNAL OF BREAST CANCER (2013)
Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo
Fang Tian et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2012)
Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formation
Robert A. Forrest et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Beneficial effects of curcumin on antitumor activity and adverse reactions of doxorubicin
Yasuyuki Sadzuka et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells
Elisa Latorre et al.
MOLECULAR CANCER (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile
Ga Young Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Sensitization of Head and Neck Cancer to Cisplatin Through the Use of a Novel Curcumin Analog
Waleed M. Abuzeid et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2011)
HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition
Karuppaiyah Selvendiran et al.
CANCER BIOLOGY & THERAPY (2011)
Curcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo
Lynne M. Howells et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Curcumin Enhances the Efficacy of Chemotherapy by Tailoring p65NFκB-p300 Cross-talk in Favor of p53-p300 in Breast Cancer
Gouri Sankar Sen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Synergistic Effect of Curcumin and Cisplatin via Down-Regulation of Thymidine Phosphorylase and Excision Repair Cross-Complementary 1 (ERCC1)
Min-Shao Tsai et al.
MOLECULAR PHARMACOLOGY (2011)
Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer
C. N. Sreekanth et al.
ONCOGENE (2011)
被撤回的出版物: Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF (Retracted article. See vol. 78, pg. 5466, 2018)
Shadan Ali et al.
CANCER RESEARCH (2010)
Curcumin Enhances the Effect of Cisplatin in Suppression of Head and Neck Squamous Cell Carcinoma via Inhibition of IKKβ Protein of the NFκB Pathway
Victor M. Duarte et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Curcumin Promotes Apoptosis, Increases Chemosensitivity, and Inhibits Nuclear Factor κB in Esophageal Adenocarcinoma
Wibisono Hartojo et al.
TRANSLATIONAL ONCOLOGY (2010)
Insight into the Mechanism of Inactivation of Ribonucleotide Reductase by Gemcitabine 5′-Diphosphate in the Presence or Absence of Reductant
Erin Artin et al.
BIOCHEMISTRY (2009)
Curcumin Sensitizes Lung Cancer Cells to Cisplatin-Induced Apoptosis Through Superoxide Anion-Mediated Bcl-2 Degradation
Pithi Chanvorachote et al.
CANCER INVESTIGATION (2009)
Identification of genes conferring resistance to 5-fluorouracil
Byoung Kwon Yoo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes
A. M. Calcagno et al.
BRITISH JOURNAL OF CANCER (2008)
Curcumin: From ancient medicine to current clinical trials
H. Hatcher et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Platinum resistance: The role of DNA repair pathways
Lainie P. Martin et al.
CLINICAL CANCER RESEARCH (2008)
Topoisomerase levels determine chemotherapy response in vitro and in vivo
Darren J. Burgess et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A systematic review of platinum and taxane resistance from bench to clinic: An inverse relationship
Britta Stordal et al.
CANCER TREATMENT REVIEWS (2007)
Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κB-regulated gene products
Ajaikumar B. Kunnumakkara et al.
CANCER RESEARCH (2007)
Curcurain enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells
Heather Wahl et al.
GYNECOLOGIC ONCOLOGY (2007)
Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK
Nathan M. Weir et al.
CANCER BIOLOGY & THERAPY (2007)
Synthetic metallomolecules as agents for the control of DNA structure
Adair D. Richards et al.
CHEMICAL SOCIETY REVIEWS (2007)
Review: Side effects of approved molecular targeted therapies in solid cancers
Christian Widakowich et al.
ONCOLOGIST (2007)
Role of tyrosine kinase inhibitors in cancer therapy
A Arora et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression
M Notarbartolo et al.
CANCER LETTERS (2005)
NF-kB in development and progression of human cancer
X Dolcet et al.
VIRCHOWS ARCHIV (2005)
Mechanisms of Drug Resistance in Cancer Chemotherapy
Y. A. Luqmani
MEDICAL PRINCIPLES AND PRACTICE (2005)
Timeline - Chemotherapy and the war on cancer
BA Chabner et al.
NATURE REVIEWS CANCER (2005)
Mechanistic and predictive profiling of 5-fluorouracil resistance in human cancer cells
WG Wang et al.
CANCER RESEARCH (2004)
Inhibition of colonic aberrant crypt foci by curcumin in rats is affected by age
Y Kwon et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2004)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Share Paper
